Chris Bolton

New licensing deal adds fresh buzz to joint venture

By GREGORY ZELLER // A partnership between a Stony Brook biotech and a Canadian pharmaceutical-solutions provider is growing like a weed. Less than a year since introducing the world’s first DNA-based cannabis-tagging system and just five months since they upgraded the system to accommodate large-scale growers, Applied DNA Sciences and Canadian/Panamanian cohort TheraCann International Benchmark Corp. have inked an exclusive licensing deal. The skinny: a long-term licensing agreement pairing Applied DNA’s proprietary CertainT supply chain…


Smoking-hot biotech sparks key cannabis contract

By GREGORY ZELLER // It’s another new high for Applied DNA Sciences. Just days after introducing a new satellite laboratory in India to service its growing Asian-Pacific customer base, the Stony Brook-based biotech lit up again Thursday, announcing a new contract to develop molecular tracking systems for a worldwide network of legal cannabis supplies. The two-year, $1 million development and marketing agreement with Canadian supplier TheraCann International Benchmark Corp. – which provides turn-key pharmaceutical solutions…